US equities |
MU $877.55 ▲+0.00% TSLA $372.22 ▲+0.00% SPCX $147.49 ▲+0.00% SNDK $1,238.03 ▲+0.00% NVDA $210.96 ▲+0.00% NBIS $158.74 ▲+0.00% AAPL $347.73 ▲+0.00% NU $15.16 ▲+0.00%
FinancialContent

Universe Pharmaceuticals Inc - Class A Ordinary Shares (NQ:UPC)

4.340 UNCHANGED
Delayed Quote Updated: 3:59 PM EDT, Oct 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Universe Pharmaceuticals Inc - Class A Ordinary Shares

News headline image
Law Offices of Howard G. Smith Announces Investigation of Universe Pharmaceuticals INC. (UPC) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Universe Pharmaceuticals INC. (UPC) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Sizzling Stocks Under $5: UPC, ANY, NNBR, DCOY Target AI Infrastructure, Data Centers, Pharmaceutical Innovation and Biotechnology Growth
Via AB Newswire
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
From Universe Pharmaceuticals INC.
Via GlobeNewswire
News headline image
Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure
From Universe Pharmaceuticals INC.
Via GlobeNewswire
News headline image
Universe Pharmaceuticals INC Announces Share Consolidation
From Universe Pharmaceuticals INC.
Via GlobeNewswire
News headline image
Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report
From Universe Pharmaceuticals INC.
Via GlobeNewswire
News headline image
Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request
From Universe Pharmaceuticals INC.
Via GlobeNewswire
News headline image
Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering
From Universe Pharmaceuticals INC.
Via GlobeNewswire
News headline image
Universe Pharmaceuticals INC Announces Share Consolidation
From Universe Pharmaceuticals INC.
Via GlobeNewswire
News headline image
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
From Universe Pharmaceuticals INC.
Via GlobeNewswire
News headline image
Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Universe Pharmaceuticals INC
Via GlobeNewswire